Cheng Xian, Long Dingpei, Chen Lili, Jansen John A, Leeuwenburgh Sander C G, Yang Fang
Department of Dentistry-Biomaterials, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Philips van Leydenlaan 25, 6525, EX Nijmegen, the Netherlands.
Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, 210029, PR China.
Bioact Mater. 2021 Apr 28;6(11):4243-4254. doi: 10.1016/j.bioactmat.2021.03.046. eCollection 2021 Nov.
The therapeutic precision and clinical applicability of drug-eluting coatings can be substantially improved by facilitating tunable drug delivery. However, the design of coatings which allows for precise control over drug release kinetics is still a major challenge. Here, a double-layered silk fibroin (SF) coating system was constructed by sequential electrophoretic deposition. A mixture of dissolved SF (SF) molecules and pre-made SF nanospheres at different ratios was deposited as under-layer. Subsequently, this underlayer was covered by a top-layer comprising SF (SF) molecules (rich in arginylglycylaspartic acid, RGD) to improve the cellular response of the resulting double-layered coatings. Additionally, model drug doxycycline was either pre-mixed with dissolved SF molecules or pre-loaded into pre-made SF nanospheres at the same amount before their mixing and deposition. The thickness and nanosphere content of the under-layer architecture were proportional to the deposition time and nanosphere concentration in precursor mixtures, respectively. The surface topography, wettability, degradation rate and adhesion strength were comparable within the double-layered coating system. As expected, RGD-rich SF top-layer improved cell adhesion, spreading and proliferation compared with SF top-layer. Furthermore, the amount and duration of drug release increased linearly with increasing nanosphere concentration at fixed deposition time, whereas drug release amount increased linearly with increasing deposition time. These results indicate that the dosage and kinetics of loaded drugs can be quantitatively tailored by altering nanosphere concentration and deposition time as main processing parameters. Overall, this study illustrates the strong potential of pre-defining coating architecture to facilitate control over drug delivery.
通过实现可控的药物递送,可以显著提高药物洗脱涂层的治疗精度和临床适用性。然而,设计能够精确控制药物释放动力学的涂层仍然是一项重大挑战。在此,通过连续电泳沉积构建了一种双层丝素蛋白(SF)涂层系统。将溶解的SF分子与不同比例的预制SF纳米球的混合物作为底层进行沉积。随后,该底层被包含SF分子(富含精氨酰甘氨酰天冬氨酸,RGD)的顶层覆盖,以改善所得双层涂层的细胞反应。此外,模型药物多西环素在混合和沉积之前,要么与溶解的SF分子预混合,要么以相同量预加载到预制的SF纳米球中。底层结构的厚度和纳米球含量分别与沉积时间和前驱体混合物中的纳米球浓度成正比。在双层涂层系统中,表面形貌、润湿性、降解速率和粘附强度具有可比性。正如预期的那样,与SF顶层相比,富含RGD的SF顶层改善了细胞粘附、铺展和增殖。此外,在固定沉积时间下,药物释放量和持续时间随纳米球浓度增加呈线性增加,而药物释放量随沉积时间增加呈线性增加。这些结果表明,通过改变纳米球浓度和沉积时间作为主要加工参数,可以定量调整负载药物的剂量和动力学。总体而言,本研究说明了预先定义涂层结构以促进药物递送控制的强大潜力。